Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Prostatic Neoplasms 3Neoplasms 3Motor Activity 3Pancreatic Neoplasms 2Overweight 2Obesity 2Malnutrition 2Lung Neoplasms 2Colorectal Neoplasms 2Weight Loss 1Urinary Bladder Neoplasms 1Taste Disorders 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcopenia 1Rectal Neoplasms 1Patient Compliance 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Metabolic Diseases 1Lymphoma 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Hypertension 1Hypercholesterolemia 1Heart Failure 1Heart Diseases 1Esophageal Neoplasms 1

Interventions

pembrolizumab 105Specimen Handling 55Magnetic Resonance Spectroscopy 48Biopsy 47Nivolumab 40Paclitaxel 35Gemcitabine 30Radiosurgery 29Carboplatin 28Irinotecan 22Ipilimumab 22Cyclophosphamide 22Cisplatin 22trastuzumab deruxtecan 21Leucovorin 19Capecitabine 19Fluorouracil 18Cetuximab 18Bevacizumab 18130-nm albumin-bound paclitaxel 18Pemetrexed 17Fulvestrant 17Drug Therapy 16Docetaxel 16Taxes 15Oxaliplatin 15olaparib 14abemaciclib 14Radiotherapy 14palbociclib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Nutrition Assessment × 1 year × Clear all
NCT03035409 2025-11-10

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
129 enrolled 11 charts

Neoplasm Metastasis, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡